Dicarboxylic acids and derivatives
Medchemexpress LLC Ethyl Lauroyl Argina 5g
Ethyl Lauroyl Arginate Hydrochloride is an arginine derivative[1]
Apexbio Technology LLC CAL-101 (Idelalisib, GS-1101) 870281-82-6 50mg
CAL-101 (Idelalisib GS-1101 CAS 870281-82-6) is a selective inhibitor targeting the p110 isoform of phosphatidylinositol 3-kinase (PI3K) an enzyme involved in signaling pathways critical for proliferation and survival of malignant B cells By inhibiting PI3K p110 CAL-101 reduces PI3K-mediated phosphorylation of Akt and other downstream factors leading to enhanced PARP cleavage and caspase activation ultimately inducing apoptosis in malignant B cells CAL-101 has been demonstrated to counteract survival signals initiated by molecules such as CD40 ligand (CD40L) TNF- and fibronectin This agent is valuable in investigating B-cell malignancies
TARGETMOL CHEMICALS INC AVN-101 5MG
Also available in 1 mg 10 mg 25 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. AVN-101 is a very potent 5-HT7 receptor antagonist (Ki = 153 pM). AVN-101 also exhibits a rather high affinity toward histamine H1 (Ki = 0.58 nM) and adrenergic (alpha)2A (alpha)2B and (alpha)2C (Ki = 0.41-3.6 nM) receptors. AVN-101 shows a good oral bioavailability and facilitated brain-blood barrier permeability low toxicity and reasonable efficacy in animal models of CNS diseases. purity: 99%
Apexbio Technology LLC CUDC-101 1012054-59-9 50mg
CUDC-101 (CAS 1012054-59-9) is a multitargeted small molecule inhibitor that concurrently targets epidermal growth factor receptor (EGFR) HER2 and class I and II histone deacetylases (HDACs) By inhibiting EGFR and HER2 kinases directly and simultaneously blocking HDAC activity CUDC-101 downregulates multiple oncogenic signaling pathways including those mediated by Akt HER3 and MET Preclinical assessments demonstrate that CUDC-101 inhibits growth of diverse tumor cell lines and xenograft models notably including those resistant to EGFR-targeted agents such as lapatinib and erlotinib These characteristics render CUDC-101 valuable for oncology research and drug resistance studies
Selleck Chemical LLC PHI-101-E1437-100MG
PHI-101 is an orally active potent third-generation inhibitor of FLT3 that overcomes resistance to multiple drug-resistant mutations It has potential for research in relapsed or refractory acute myeloid leukemia (AML)
Medchemexpress LLC UCPH-101 | 1118460-77-7 | 98.6% | 422.48 | 10 MG
UCPH-101 is an excitatory amino acid transporter subtype 1 (EAAT1) inhibitor with an IC50 of 0.66 μM. It functions as an allosteric modulator, inducing sustained inhibition of EAAT1 through an intramonomeric site within the trimerization domain. In vitro studies show that UCPH-101 inhibits EAAT1 anion currents in a concentration-dependent manner, with a KD value of 0.34±0.03 μM. This compound is intended for research use only.
- Inhibits excitatory amino acid transporter subtype 1 (EAAT1)
- Functions as an allosteric modulator
- Demonstrates sustained inhibition of EAAT1 anion currents
- IC50 of 0.66 μM
- KD value of 0.34±0.03 μM for EAAT1 anion currents
Medchemexpress LLC 1,2-dilauroyl-sn-glycero-3-phosphoethanolamine | 59752-57-7 | MFCD00042828 | 98.0% | 579.75 g·mol⁻¹ | C29H58NO8P | 100 MG
1,2-Dilauroyl-sn-glycero-3-phosphoethanolamine (DLPE) is a phosphatidylethanolamine derivative bearing two lauroyl (C12:0) acyl chains. It is a research-grade lipid commonly used for liposome formulation and membrane model studies; typical properties include a molecular weight of 579.75 g·mol⁻¹ and high purity (98.0%).
- Phosphatidylethanolamine lipid with two lauroyl (C12:0) chains.
- Suitable for liposome synthesis and membrane model studies.
- High purity (98.0%) for research applications.
- Molecular formula C29H58NO8P and molecular weight 579.75 g·mol⁻¹.
Medchemexpress LLC JI-101 (hydrochloride) | 2514957-81-2 | 502.79 | 100 MG
JI-101 (hydrochloride) | 2514957-81-2 | 502.79 | 100 MG
Medchemexpress LLC JI-101 | 900573-88-8 | 99.0% | 466.33 | 5 MG
JI-101 is an orally available multi-kinase inhibitor of VEGFR2, PDGFRβ, and EphB4 with potent anti-cancer activity. It is for research use only and is not sold to patients.
- Orally available multi-kinase inhibitor.
- Inhibits VEGFR2, PDGFRβ, and EphB4.
- Potent anti-cancer activity.
- Stable in all preclinical and human liver microsomes.
- Rapidly absorbed after oral administration, reaching Cmax within 2 hours.
- Extensive tissue distribution with rapid and preferred uptake into lung tissue.
- Oral bioavailability is 55%.
- Primary route of elimination is feces.
Medchemexpress LLC VH 101, acid | 2408341-97-7 | 98.8% | 574.66 | C28H35FN4O6S | 10 MG
VH 101, acid is a functionalized von Hippel-Lindau (VHL) E3 ligase ligand developed for PROTAC research and conjugation chemistry. The molecule includes an E3 ligase recognition motif and an alkyl linker terminating in a primary amine, facilitating attachment to target protein ligands.
- Designed for use as a VHL E3 ligase ligand in PROTAC development.
- Alkyl linker with terminal amine enables straightforward conjugation chemistry.
- High reported purity suitable for research applications.
- Supplied in small research-scale quantities for synthetic work and assay testing.
Medchemexpress LLC Vnt-101 | 2894060-67-2 | 456.41 | C21H23F3N2O6 | 10 MG
VNT-101 is a small-molecule, orally active inhibitor of influenza A virus nucleoprotein (NP) oligomerization. It disrupts NP-NP protein-protein interactions to destabilize the viral ribonucleoprotein complex and has been used in vitro and in vivo to study antiviral activity across multiple influenza A subtypes.
- Disrupts nucleoprotein oligomerization to inhibit viral replication.
- Orally bioavailable small molecule suitable for in vivo studies.
- Demonstrated activity against multiple influenza A subtypes.
- Molecular weight 456.41 and molecular formula C21H23F3N2O6.
- CAS number 2894060-67-2 for substance identification.
- Supplied as a solid for research use with supporting characterization data.
Medchemexpress LLC 4H-1-Benzopyran-3-carbonitrile, 2-amino-5,6,7,8-tetrahydro-4-(4-methoxyphenyl)-7-(1-naphthalenyl) | 1118460-77-7 | 98.61% | 422.48 | 100 MG
UCPH-101 is a potent excitatory amino acid transporter subtype 1 (EAAT1) inhibitor, demonstrating an IC50 of 0.66 μM. This compound is intended for research applications only and is not suitable for patient use.
- Inhibits EAAT1 anion currents with a KD value of 0.34±0.03 μM (Hill=1.3±0.13, n≥9).
- Causes a small but significant decrease in total expression levels of HA-EAAT1 and HA-GLAST in cells preincubated with 100 μM UCPH-101 (p=0.048).
Medchemexpress LLC UCPH-101 excitatory amino acid transporter subtype 1 inhibitor | 1118460-77-7 | 98.6% | 422.48 | 1 ML
UCPH-101 is an excitatory amino acid transporter subtype 1 (EAAT1) inhibitor with an IC50 of 0.66 μM. This compound is suitable for research applications. It presents as a white to off-white solid.
- Molecular weight: 422.48
- Formula: C27H22N2O3
- Appearance: Solid
- Color: White to off-white
- Shipping: Room temperature in continental US (may vary elsewhere)
- Storage: Powder at -20°C for 3 years or 4°C for 2 years; in solvent at -80°C for 2 years or -20°C for 1 year
- Solubility: In DMSO: ≥ 50 mg/mL (118.35 mM)
![Medchemexpress LLC N-(2-(1H-indol-3-yl)ethyl)-5-(5-fluoropyridin-3-yl)-3-methylpyrazolo[1,5-a]pyrimidin-7-amine | 2247950-73-6 | 98.0% | C22H19FN6 | 10MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000261386.png-250.jpg)
Medchemexpress LLC N-(2-(1H-indol-3-yl)ethyl)-5-(5-fluoropyridin-3-yl)-3-methylpyrazolo[1,5-a]pyrimidin-7-amine | 2247950-73-6 | 98.0% | C22H19FN6 | 10MG
KYN-101 is a small-molecule, selective, orally active antagonist of the aryl hydrocarbon receptor (AHR) supplied for laboratory research. It reduces CYP1A1 mRNA expression and has demonstrated anti-cancer activity in preclinical studies, making it suitable for mechanistic studies of AHR signaling and oncology research.
- Selective AHR inhibition with reported nanomolar potency.
- Orally active in preclinical models.
- Reduces CYP1A1 mRNA expression in cellular assays.
- Useful for mechanistic studies of AHR signaling and cancer biology.
- Available as solid and ready-to-use DMSO solutions for assay setup.
- High purity suitable for research applications.